Table 2.

Effect of treatment on the values of clinical measures in follow-up IMN patients.

	Before treatment	After treatment
Age, years	39 (28–58) 3/3
Female/male
Monocytes (109/L)	0.3 (0.2–0.4)	0.6 (0.4–0.8)∗
Serum uric acid (μmol/L)	300 (166–450)	320 (180–420)
Triglycerides (mmol/L)	2.5 (0.7–3.6)	1.9 (0.97–4)
Total cholesterol (mmol/L)	6.5 (5.8–10)	6 (4.3–7.8)
Serum albumin (g/L)	25 (18–28)	30 (26–35)∗
Urinary proteins (g/24 h)	7.8 (2.5–10)	1.6 (0.5–3)∗
eGFR (CKD-EPI) (mL/min/1.73 m2)	110 (95–120)	118 (106–125)

Data are presented as median range. ^∗P < 0.05 versus the values before treatment.